nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—TRPV1—sciatic nerve—sarcoma	0.08	0.123	CbGeAlD
Icosapent—PTGS2—Etoposide—sarcoma	0.0356	0.542	CbGbCtD
Icosapent—PTGS1—Etoposide—sarcoma	0.0301	0.458	CbGbCtD
Icosapent—PPARG—dermis—sarcoma	0.0272	0.042	CbGeAlD
Icosapent—PPARG—periosteum—sarcoma	0.0226	0.0348	CbGeAlD
Icosapent—FABP7—mammary gland—sarcoma	0.0181	0.0279	CbGeAlD
Icosapent—PPARG—leg—sarcoma	0.018	0.0277	CbGeAlD
Icosapent—PPARG—forelimb—sarcoma	0.0178	0.0275	CbGeAlD
Icosapent—SLC8A1—embryo—sarcoma	0.0168	0.0259	CbGeAlD
Icosapent—PPARG—hindlimb—sarcoma	0.0161	0.0248	CbGeAlD
Icosapent—PPARG—Teniposide—Etoposide—sarcoma	0.015	1	CbGdCrCtD
Icosapent—SLC8A1—hematopoietic system—sarcoma	0.015	0.0231	CbGeAlD
Icosapent—PPARD—mammary gland—sarcoma	0.0143	0.022	CbGeAlD
Icosapent—PPARD—Ectoderm Differentiation—PTPRB—sarcoma	0.014	0.0535	CbGpPWpGaD
Icosapent—PPARG—appendage—sarcoma	0.0138	0.0212	CbGeAlD
Icosapent—SLC8A1—smooth muscle tissue—sarcoma	0.0132	0.0203	CbGeAlD
Icosapent—FABP7—embryo—sarcoma	0.0123	0.019	CbGeAlD
Icosapent—FADS1—myometrium—sarcoma	0.0116	0.0179	CbGeAlD
Icosapent—PTGS2—periosteum—sarcoma	0.0115	0.0178	CbGeAlD
Icosapent—FABP7—connective tissue—sarcoma	0.0106	0.0164	CbGeAlD
Icosapent—ACSL4—myometrium—sarcoma	0.0106	0.0163	CbGeAlD
Icosapent—FADS1—seminal vesicle—sarcoma	0.0105	0.0162	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—PLCG1—sarcoma	0.0105	0.0402	CbGpPWpGaD
Icosapent—ACSL3—testis—sarcoma	0.00991	0.0153	CbGeAlD
Icosapent—ACSL4—seminal vesicle—sarcoma	0.00955	0.0147	CbGeAlD
Icosapent—ACSL3—liver—sarcoma	0.00937	0.0144	CbGeAlD
Icosapent—PTGS2—leg—sarcoma	0.00919	0.0142	CbGeAlD
Icosapent—ACSL4—hematopoietic system—sarcoma	0.00908	0.014	CbGeAlD
Icosapent—FADS1—smooth muscle tissue—sarcoma	0.0088	0.0136	CbGeAlD
Icosapent—ACSL4—connective tissue—sarcoma	0.00874	0.0135	CbGeAlD
Icosapent—PPARD—hematopoietic system—sarcoma	0.00871	0.0134	CbGeAlD
Icosapent—PPARG—endothelium—sarcoma	0.00831	0.0128	CbGeAlD
Icosapent—PTGS2—hindlimb—sarcoma	0.0082	0.0126	CbGeAlD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—TLE1—sarcoma	0.0082	0.0314	CbGpPWpGaD
Icosapent—PTGS2—cartilage tissue—sarcoma	0.00808	0.0125	CbGeAlD
Icosapent—FADS1—cardiac atrium—sarcoma	0.00759	0.0117	CbGeAlD
Icosapent—FADS1—uterus—sarcoma	0.00755	0.0116	CbGeAlD
Icosapent—FFAR1—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—sarcoma	0.00721	0.0276	CbGpPWpGaD
Icosapent—PTGS2—appendage—sarcoma	0.00704	0.0108	CbGeAlD
Icosapent—ACSL4—cardiac atrium—sarcoma	0.00689	0.0106	CbGeAlD
Icosapent—ACSL4—uterus—sarcoma	0.00686	0.0106	CbGeAlD
Icosapent—SLC8A1—Calcium Regulation in the Cardiac Cell—GJA4—sarcoma	0.00678	0.026	CbGpPWpGaD
Icosapent—PPARG—mammary gland—sarcoma	0.0067	0.0103	CbGeAlD
Icosapent—FADS1—tendon—sarcoma	0.00661	0.0102	CbGeAlD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—CALD1—sarcoma	0.00657	0.0252	CbGpPWpGaD
Icosapent—FFAR1—Incretin synthesis, secretion, and inactivation—CTNNB1—sarcoma	0.00641	0.0246	CbGpPWpGaD
Icosapent—FADS1—bone marrow—sarcoma	0.00641	0.00988	CbGeAlD
Icosapent—PPARD—lymphoid tissue—sarcoma	0.00613	0.00946	CbGeAlD
Icosapent—ACSL4—tendon—sarcoma	0.00601	0.00926	CbGeAlD
Icosapent—ACSL4—bone marrow—sarcoma	0.00582	0.00897	CbGeAlD
Icosapent—PPARD—Ectoderm Differentiation—PAX3—sarcoma	0.00579	0.0222	CbGpPWpGaD
Icosapent—PPARD—tendon—sarcoma	0.00577	0.00889	CbGeAlD
Icosapent—PPARG—Regulation of retinoblastoma protein—PAX3—sarcoma	0.00571	0.0219	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—CREB1—sarcoma	0.00565	0.0217	CbGpPWpGaD
Icosapent—FADS1—testis—sarcoma	0.00548	0.00844	CbGeAlD
Icosapent—TRPV1—testis—sarcoma	0.00548	0.00844	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—CREB1—sarcoma	0.0054	0.0207	CbGpPWpGaD
Icosapent—FADS1—liver—sarcoma	0.00518	0.00798	CbGeAlD
Icosapent—ACSL4—testis—sarcoma	0.00497	0.00767	CbGeAlD
Icosapent—PPARD—testis—sarcoma	0.00478	0.00736	CbGeAlD
Icosapent—ACSL4—liver—sarcoma	0.0047	0.00725	CbGeAlD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—TEK—sarcoma	0.00467	0.0179	CbGpPWpGaD
Icosapent—PPARG—embryo—sarcoma	0.00457	0.00705	CbGeAlD
Icosapent—PPARD—liver—sarcoma	0.00451	0.00696	CbGeAlD
Icosapent—PTGS1—endothelium—sarcoma	0.00444	0.00685	CbGeAlD
Icosapent—PTGS2—endothelium—sarcoma	0.00425	0.00655	CbGeAlD
Icosapent—PPARG—Regulation of retinoblastoma protein—SMARCB1—sarcoma	0.00415	0.0159	CbGpPWpGaD
Icosapent—PPARG—hematopoietic system—sarcoma	0.00408	0.00629	CbGeAlD
Icosapent—FADS1—lymph node—sarcoma	0.00397	0.00612	CbGeAlD
Icosapent—PPARG—connective tissue—sarcoma	0.00393	0.00606	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—CCND1—sarcoma	0.00389	0.0149	CbGpPWpGaD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—FOXO1—sarcoma	0.0038	0.0146	CbGpPWpGaD
Icosapent—ACSL4—lymph node—sarcoma	0.00361	0.00556	CbGeAlD
Icosapent—PPARG—smooth muscle tissue—sarcoma	0.0036	0.00554	CbGeAlD
Icosapent—PPARG—skin of body—sarcoma	0.00355	0.00547	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—NRAS—sarcoma	0.00351	0.0134	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—SRC—sarcoma	0.00348	0.0133	CbGpPWpGaD
Icosapent—PPARD—lymph node—sarcoma	0.00346	0.00534	CbGeAlD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—PLCG1—sarcoma	0.00338	0.0129	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—sarcoma	0.00335	0.0128	CbGpPWpGaD
Icosapent—PTGS2—S1P1 pathway—PLCG1—sarcoma	0.00335	0.0128	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—ATF1—sarcoma	0.00321	0.0123	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—MYOD1—sarcoma	0.00314	0.012	CbGpPWpGaD
Icosapent—PPARG—uterus—sarcoma	0.00308	0.00475	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—KRAS—sarcoma	0.00302	0.0116	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—MITF—sarcoma	0.00292	0.0112	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—sarcoma	0.00288	0.011	CbGpPWpGaD
Icosapent—PPARG—lymphoid tissue—sarcoma	0.00287	0.00443	CbGeAlD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—CREB1—sarcoma	0.00276	0.0106	CbGpPWpGaD
Icosapent—PPARG—tendon—sarcoma	0.0027	0.00417	CbGeAlD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.0027	0.0103	CbGpPWpGaD
Icosapent—PPARG—bone marrow—sarcoma	0.00262	0.00403	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—HRAS—sarcoma	0.00257	0.00983	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—sarcoma	0.00245	0.00939	CbGpPWpGaD
Icosapent—PTGS2—myometrium—sarcoma	0.00243	0.00375	CbGeAlD
Icosapent—PTGS2—S1P1 pathway—PDGFRB—sarcoma	0.00237	0.00909	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.00234	0.00896	CbGpPWpGaD
Icosapent—PTGS2—embryo—sarcoma	0.00234	0.0036	CbGeAlD
Icosapent—PTGS1—seminal vesicle—sarcoma	0.0023	0.00354	CbGeAlD
Icosapent—SLC8A1—Hemostasis—TEK—sarcoma	0.00227	0.00871	CbGpPWpGaD
Icosapent—SLC8A1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—sarcoma	0.00224	0.00859	CbGpPWpGaD
Icosapent—PPARG—testis—sarcoma	0.00224	0.00345	CbGeAlD
Icosapent—PTGS2—seminal vesicle—sarcoma	0.0022	0.00338	CbGeAlD
Icosapent—PTGS1—hematopoietic system—sarcoma	0.00218	0.00336	CbGeAlD
Icosapent—FFAR1—Peptide hormone metabolism—CTNNB1—sarcoma	0.00217	0.00833	CbGpPWpGaD
Icosapent—PPARG—liver—sarcoma	0.00212	0.00326	CbGeAlD
Icosapent—PTGS1—connective tissue—sarcoma	0.0021	0.00324	CbGeAlD
Icosapent—PTGS2—hematopoietic system—sarcoma	0.00209	0.00322	CbGeAlD
Icosapent—SLC8A1—Hemostasis—ANGPT2—sarcoma	0.00208	0.00797	CbGpPWpGaD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—CCND1—sarcoma	0.00202	0.00773	CbGpPWpGaD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—JUN—sarcoma	0.00201	0.00771	CbGpPWpGaD
Icosapent—PTGS2—connective tissue—sarcoma	0.00201	0.0031	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.002	0.00768	CbGpPWpGaD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—CTNNB1—sarcoma	0.002	0.00765	CbGpPWpGaD
Icosapent—PTGS2—S1P1 pathway—KDR—sarcoma	0.00197	0.00753	CbGpPWpGaD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.00195	0.00748	CbGpPWpGaD
Icosapent—PTGS1—smooth muscle tissue—sarcoma	0.00192	0.00296	CbGeAlD
Icosapent—PTGS1—skin of body—sarcoma	0.0019	0.00293	CbGeAlD
Icosapent—PTGS2—smooth muscle tissue—sarcoma	0.00184	0.00283	CbGeAlD
Icosapent—PTGS2—skin of body—sarcoma	0.00181	0.0028	CbGeAlD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—CREB1—sarcoma	0.00174	0.00666	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—FOXO1—sarcoma	0.00168	0.00644	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—VEGFC—sarcoma	0.00167	0.00639	CbGpPWpGaD
Icosapent—PTGS1—cardiac atrium—sarcoma	0.00166	0.00256	CbGeAlD
Icosapent—PTGS1—uterus—sarcoma	0.00165	0.00254	CbGeAlD
Icosapent—PPARG—lymph node—sarcoma	0.00162	0.0025	CbGeAlD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—MYC—sarcoma	0.00162	0.0062	CbGpPWpGaD
Icosapent—PTGS2—uterus—sarcoma	0.00158	0.00243	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—CXCR4—sarcoma	0.00153	0.00585	CbGpPWpGaD
Icosapent—PTGS2—lymphoid tissue—sarcoma	0.00147	0.00226	CbGeAlD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	0.00145	0.00556	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—HBA1—sarcoma	0.00145	0.00555	CbGpPWpGaD
Icosapent—PTGS1—tendon—sarcoma	0.00144	0.00223	CbGeAlD
Icosapent—PTGS2—C-MYB transcription factor network—MYOD1—sarcoma	0.00144	0.00552	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CD34—sarcoma	0.00144	0.00552	CbGpPWpGaD
Icosapent—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	0.00142	0.00545	CbGpPWpGaD
Icosapent—PTGS2—tendon—sarcoma	0.00138	0.00213	CbGeAlD
Icosapent—PTGS2—bone marrow—sarcoma	0.00134	0.00206	CbGeAlD
Icosapent—SLC8A1—Hemostasis—PLCG1—sarcoma	0.00131	0.00502	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—JUN—sarcoma	0.00125	0.00479	CbGpPWpGaD
Icosapent—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	0.00124	0.00476	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—CREB1—sarcoma	0.00122	0.00467	CbGpPWpGaD
Icosapent—PTGS1—testis—sarcoma	0.0012	0.00184	CbGeAlD
Icosapent—PTGS2—Selenium Micronutrient Network—HBA1—sarcoma	0.00115	0.00441	CbGpPWpGaD
Icosapent—PPARG—SREBP signalling—CREB1—sarcoma	0.0011	0.00423	CbGpPWpGaD
Icosapent—PTGS2—S1P1 pathway—VEGFA—sarcoma	0.00108	0.00415	CbGpPWpGaD
Icosapent—PTGS2—liver—sarcoma	0.00108	0.00167	CbGeAlD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—CCND1—sarcoma	0.00107	0.00409	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—JUN—sarcoma	0.00106	0.00408	CbGpPWpGaD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.00106	0.00405	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	0.00106	0.00405	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—CTNNB1—sarcoma	0.00106	0.00405	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	0.00103	0.00394	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MYOG—sarcoma	0.00102	0.0039	CbGpPWpGaD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—CCND1—sarcoma	0.000998	0.00382	CbGpPWpGaD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—sarcoma	0.000988	0.00379	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—FUS—sarcoma	0.000952	0.00365	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—MDM2—sarcoma	0.000947	0.00363	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—FOXO1—sarcoma	0.000917	0.00352	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—sarcoma	0.000908	0.00348	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.0009	0.00345	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ENO2—sarcoma	0.000896	0.00343	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—HBA1—sarcoma	0.00089	0.00341	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—sarcoma	0.000884	0.00339	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—CTNNB1—sarcoma	0.00087	0.00333	CbGpPWpGaD
Icosapent—PTGS1—lymph node—sarcoma	0.000867	0.00134	CbGeAlD
Icosapent—FFAR1—GPCR downstream signaling—CXCR4—sarcoma	0.000862	0.00331	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—sarcoma	0.000855	0.00328	CbGpPWpGaD
Icosapent—PPARD—Ectoderm Differentiation—CTNNB1—sarcoma	0.000829	0.00318	CbGpPWpGaD
Icosapent—PTGS2—lymph node—sarcoma	0.000829	0.00128	CbGeAlD
Icosapent—PPARG—Regulation of retinoblastoma protein—CCND1—sarcoma	0.000825	0.00316	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—JUN—sarcoma	0.000823	0.00315	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.00082	0.00314	CbGpPWpGaD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—MYC—sarcoma	0.000801	0.00307	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CXCR4—sarcoma	0.000783	0.003	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000774	0.00297	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EZR—sarcoma	0.00077	0.00295	CbGpPWpGaD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.00076	0.00291	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PLCG1—sarcoma	0.00076	0.00291	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ENO2—sarcoma	0.000751	0.00288	CbGpPWpGaD
Icosapent—FADS1—Metabolism—HBA1—sarcoma	0.000746	0.00286	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TLE1—sarcoma	0.000726	0.00278	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—sarcoma	0.000702	0.00269	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000694	0.00266	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ENO2—sarcoma	0.000679	0.0026	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ENO2—sarcoma	0.000679	0.0026	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—HBA1—sarcoma	0.000675	0.00258	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—HBA1—sarcoma	0.000675	0.00258	CbGpPWpGaD
Icosapent—PPARD—Ectoderm Differentiation—MYC—sarcoma	0.000672	0.00257	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—CREB1—sarcoma	0.000665	0.00255	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.000658	0.00252	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PLCG1—sarcoma	0.000637	0.00244	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MYOD1—sarcoma	0.000628	0.00241	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFC—sarcoma	0.000613	0.00235	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	0.000588	0.00225	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PLCG1—sarcoma	0.000576	0.00221	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PLCG1—sarcoma	0.000576	0.00221	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	0.000572	0.00219	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—KIT—sarcoma	0.000551	0.00211	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000548	0.0021	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—MMP2—sarcoma	0.000535	0.00205	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000534	0.00205	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000527	0.00202	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—FUS—sarcoma	0.00052	0.00199	CbGpPWpGaD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000502	0.00192	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—IL2—sarcoma	0.000499	0.00191	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000491	0.00188	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FLT1—sarcoma	0.00049	0.00188	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PLCG1—sarcoma	0.000482	0.00185	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.00048	0.00184	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—CTNNB1—sarcoma	0.000475	0.00182	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—CREB1—sarcoma	0.00047	0.0018	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCR4—sarcoma	0.000463	0.00177	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ATF1—sarcoma	0.000457	0.00175	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—PTPRC—sarcoma	0.000454	0.00174	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000454	0.00174	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—PLCG1—sarcoma	0.000444	0.0017	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—SRC—sarcoma	0.000435	0.00167	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—VEGFA—sarcoma	0.000424	0.00162	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CREB1—sarcoma	0.00042	0.00161	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—NRAS—sarcoma	0.000419	0.0016	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CTNNB1—sarcoma	0.00041	0.00157	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000386	0.00148	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ENO2—sarcoma	0.000382	0.00146	CbGpPWpGaD
Icosapent—PPARD—Metabolism—HBA1—sarcoma	0.000379	0.00145	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CCND1—sarcoma	0.000378	0.00145	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000369	0.00141	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—KRAS—sarcoma	0.00036	0.00138	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IGF1R—sarcoma	0.000359	0.00138	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.000342	0.0356	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—FOXO1—sarcoma	0.000342	0.00131	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—IL2—sarcoma	0.000342	0.00131	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PDGFRB—sarcoma	0.000341	0.00131	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.000339	0.0353	CcSEcCtD
Icosapent—PPARG—Circadian rythm related genes—JUN—sarcoma	0.000338	0.00129	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PDGFRA—sarcoma	0.000336	0.00129	CbGpPWpGaD
Icosapent—Alanine aminotransferase increased—Thiotepa—sarcoma	0.000335	0.0348	CcSEcCtD
Icosapent—PTGS2—C-MYB transcription factor network—NRAS—sarcoma	0.000326	0.00125	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PLCG1—sarcoma	0.000324	0.00124	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—TP53—sarcoma	0.00032	0.00123	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—FOXO1—sarcoma	0.000315	0.00121	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL2—sarcoma	0.00031	0.00119	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—HRAS—sarcoma	0.000306	0.00117	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—MYC—sarcoma	0.000303	0.00116	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Vincristine—sarcoma	0.000303	0.0315	CcSEcCtD
Icosapent—PTGS2—Spinal Cord Injury—IL2—sarcoma	0.000296	0.00113	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.000295	0.0307	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.000289	0.0301	CcSEcCtD
Icosapent—PTGS2—Spinal Cord Injury—CCND1—sarcoma	0.000288	0.0011	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KDR—sarcoma	0.000283	0.00108	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	0.00028	0.00107	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000272	0.00104	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KDR—sarcoma	0.000261	0.000999	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KIT—sarcoma	0.00026	0.000998	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—NRAS—sarcoma	0.00026	0.000998	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—MYC—sarcoma	0.000257	0.000986	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CREB1—sarcoma	0.000248	0.00095	CbGpPWpGaD
Icosapent—Alanine aminotransferase increased—Etoposide—sarcoma	0.000241	0.025	CcSEcCtD
Icosapent—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	0.000238	0.000913	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—EGFR—sarcoma	0.000237	0.000909	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MYC—sarcoma	0.000231	0.000886	CbGpPWpGaD
Icosapent—Malnutrition—Thiotepa—sarcoma	0.000229	0.0238	CcSEcCtD
Icosapent—PPARG—Developmental Biology—CREB1—sarcoma	0.000229	0.000876	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—EGFR—sarcoma	0.000226	0.000866	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000225	0.000862	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—KRAS—sarcoma	0.000224	0.000859	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TP53—sarcoma	0.000223	0.000854	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP2—sarcoma	0.000213	0.000816	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ENO2—sarcoma	0.000208	0.000798	CbGpPWpGaD
Icosapent—Eructation—Epirubicin—sarcoma	0.000207	0.0215	CcSEcCtD
Icosapent—PPARG—Metabolism—HBA1—sarcoma	0.000207	0.000793	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MDM2—sarcoma	0.000205	0.000786	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000196	0.000751	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000196	0.00075	CbGpPWpGaD
Icosapent—Arthralgia—Thiotepa—sarcoma	0.000195	0.0203	CcSEcCtD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000194	0.000744	CbGpPWpGaD
Icosapent—Dysgeusia—Mitoxantrone—sarcoma	0.000193	0.0201	CcSEcCtD
Icosapent—Eructation—Doxorubicin—sarcoma	0.000192	0.0199	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—HRAS—sarcoma	0.00019	0.00073	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—sarcoma	0.00019	0.000727	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL2—sarcoma	0.000183	0.000702	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCND1—sarcoma	0.000179	0.000684	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—JUN—sarcoma	0.000178	0.000683	CbGpPWpGaD
Icosapent—PTGS2—Disease—TLE1—sarcoma	0.000177	0.000678	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CTNNB1—sarcoma	0.000177	0.000678	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PLCG1—sarcoma	0.000177	0.000677	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000175	0.000672	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000171	0.000655	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00017	0.0177	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000169	0.0176	CcSEcCtD
Icosapent—Arthralgia—Mitoxantrone—sarcoma	0.000168	0.0175	CcSEcCtD
Icosapent—Anaphylactic shock—Vincristine—sarcoma	0.000166	0.0172	CcSEcCtD
Icosapent—Dyspepsia—Thiotepa—sarcoma	0.000164	0.0171	CcSEcCtD
Icosapent—PPARG—Developmental Biology—CTNNB1—sarcoma	0.000163	0.000625	CbGpPWpGaD
Icosapent—Anaphylactic shock—Mitoxantrone—sarcoma	0.000161	0.0168	CcSEcCtD
Icosapent—Gastrointestinal disorder—Thiotepa—sarcoma	0.000161	0.0168	CcSEcCtD
Icosapent—Dysgeusia—Etoposide—sarcoma	0.000161	0.0167	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—SRC—sarcoma	0.00016	0.000613	CbGpPWpGaD
Icosapent—PTGS2—Disease—NPM1—sarcoma	0.00016	0.000612	CbGpPWpGaD
Icosapent—Constipation—Thiotepa—sarcoma	0.00016	0.0166	CcSEcCtD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000157	0.000603	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFA—sarcoma	0.000156	0.000597	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NRAS—sarcoma	0.000154	0.000589	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000154	0.000589	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Vincristine—sarcoma	0.000151	0.0157	CcSEcCtD
Icosapent—PPARG—Developmental Biology—SRC—sarcoma	0.000148	0.000565	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000147	0.0153	CcSEcCtD
Icosapent—PTGS1—Metabolism—ENO2—sarcoma	0.000146	0.000559	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000145	0.000557	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HBA1—sarcoma	0.000145	0.000556	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—sarcoma	0.000144	0.000551	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MYC—sarcoma	0.000143	0.000549	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Vincristine—sarcoma	0.000143	0.0149	CcSEcCtD
Icosapent—PPARG—Developmental Biology—NRAS—sarcoma	0.000142	0.000544	CbGpPWpGaD
Icosapent—Dyspepsia—Mitoxantrone—sarcoma	0.000142	0.0148	CcSEcCtD
Icosapent—Constipation—Vincristine—sarcoma	0.000142	0.0147	CcSEcCtD
Icosapent—PPARG—Generic Transcription Pathway—MYC—sarcoma	0.00014	0.000538	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—sarcoma	0.00014	0.000537	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO2—sarcoma	0.000138	0.00053	CbGpPWpGaD
Icosapent—Constipation—Mitoxantrone—sarcoma	0.000138	0.0143	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000138	0.0143	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000135	0.014	CcSEcCtD
Icosapent—Anaphylactic shock—Etoposide—sarcoma	0.000134	0.0139	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—KRAS—sarcoma	0.000132	0.000507	CbGpPWpGaD
Icosapent—Pruritus—Thiotepa—sarcoma	0.000132	0.0137	CcSEcCtD
Icosapent—PPARG—Developmental Biology—EGFR—sarcoma	0.000129	0.000496	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000129	0.000495	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000127	0.0133	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000125	0.013	CcSEcCtD
Icosapent—PPARD—Gene Expression—MYC—sarcoma	0.000124	0.000475	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PLCG1—sarcoma	0.000124	0.000474	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—sarcoma	0.000122	0.000468	CbGpPWpGaD
Icosapent—Vomiting—Thiotepa—sarcoma	0.000119	0.0123	CcSEcCtD
Icosapent—Vomiting—Dactinomycin—sarcoma	0.000118	0.0123	CcSEcCtD
Icosapent—Rash—Thiotepa—sarcoma	0.000118	0.0122	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—TP53—sarcoma	0.000118	0.000451	CbGpPWpGaD
Icosapent—Dermatitis—Thiotepa—sarcoma	0.000118	0.0122	CcSEcCtD
Icosapent—PTGS2—Disease—PLCG1—sarcoma	0.000117	0.00045	CbGpPWpGaD
Icosapent—Rash—Dactinomycin—sarcoma	0.000117	0.0122	CcSEcCtD
Icosapent—PTGS2—Metabolism—ENO2—sarcoma	0.000116	0.000444	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Etoposide—sarcoma	0.000116	0.012	CcSEcCtD
Icosapent—PTGS2—Metabolism—HBA1—sarcoma	0.000115	0.000441	CbGpPWpGaD
Icosapent—Constipation—Etoposide—sarcoma	0.000115	0.0119	CcSEcCtD
Icosapent—PTGS2—Disease—CXCR4—sarcoma	0.000113	0.000432	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—sarcoma	0.000113	0.000431	CbGpPWpGaD
Icosapent—Vomiting—Vincristine—sarcoma	0.000105	0.0109	CcSEcCtD
Icosapent—Rash—Vincristine—sarcoma	0.000104	0.0109	CcSEcCtD
Icosapent—Dermatitis—Vincristine—sarcoma	0.000104	0.0108	CcSEcCtD
Icosapent—PPARG—Developmental Biology—HRAS—sarcoma	0.000104	0.000398	CbGpPWpGaD
Icosapent—Vomiting—Mitoxantrone—sarcoma	0.000103	0.0107	CcSEcCtD
Icosapent—Rash—Mitoxantrone—sarcoma	0.000102	0.0106	CcSEcCtD
Icosapent—Dermatitis—Mitoxantrone—sarcoma	0.000102	0.0106	CcSEcCtD
Icosapent—PTGS2—Metabolism—PLCG1—sarcoma	9.83e-05	0.000377	CbGpPWpGaD
Icosapent—Pruritus—Etoposide—sarcoma	9.49e-05	0.00987	CcSEcCtD
Icosapent—Malnutrition—Epirubicin—sarcoma	9.21e-05	0.00958	CcSEcCtD
Icosapent—Dysgeusia—Epirubicin—sarcoma	9.02e-05	0.00938	CcSEcCtD
Icosapent—Vomiting—Etoposide—sarcoma	8.53e-05	0.00887	CcSEcCtD
Icosapent—Malnutrition—Doxorubicin—sarcoma	8.52e-05	0.00886	CcSEcCtD
Icosapent—Rash—Etoposide—sarcoma	8.46e-05	0.0088	CcSEcCtD
Icosapent—Dermatitis—Etoposide—sarcoma	8.45e-05	0.00879	CcSEcCtD
Icosapent—Dysgeusia—Doxorubicin—sarcoma	8.35e-05	0.00868	CcSEcCtD
Icosapent—PTGS2—Disease—FOXO1—sarcoma	8.33e-05	0.000319	CbGpPWpGaD
Icosapent—PTGS2—Disease—PDGFRB—sarcoma	8.31e-05	0.000319	CbGpPWpGaD
Icosapent—PTGS2—Disease—PDGFRA—sarcoma	8.18e-05	0.000314	CbGpPWpGaD
Icosapent—Arthralgia—Epirubicin—sarcoma	7.84e-05	0.00816	CcSEcCtD
Icosapent—Anaphylactic shock—Epirubicin—sarcoma	7.52e-05	0.00782	CcSEcCtD
Icosapent—Arthralgia—Doxorubicin—sarcoma	7.26e-05	0.00755	CcSEcCtD
Icosapent—Anaphylactic shock—Doxorubicin—sarcoma	6.96e-05	0.00723	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Epirubicin—sarcoma	6.85e-05	0.00712	CcSEcCtD
Icosapent—PPARG—Gene Expression—MYC—sarcoma	6.76e-05	0.000259	CbGpPWpGaD
Icosapent—Dyspepsia—Epirubicin—sarcoma	6.62e-05	0.00688	CcSEcCtD
Icosapent—Gastrointestinal disorder—Epirubicin—sarcoma	6.49e-05	0.00675	CcSEcCtD
Icosapent—Constipation—Epirubicin—sarcoma	6.43e-05	0.00669	CcSEcCtD
Icosapent—PTGS2—Disease—KIT—sarcoma	6.35e-05	0.000243	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.34e-05	0.00659	CcSEcCtD
Icosapent—Dyspepsia—Doxorubicin—sarcoma	6.12e-05	0.00637	CcSEcCtD
Icosapent—PTGS2—Disease—CREB1—sarcoma	6.04e-05	0.000231	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Doxorubicin—sarcoma	6.01e-05	0.00625	CcSEcCtD
Icosapent—Constipation—Doxorubicin—sarcoma	5.95e-05	0.00619	CcSEcCtD
Icosapent—Pruritus—Epirubicin—sarcoma	5.32e-05	0.00553	CcSEcCtD
Icosapent—PTGS2—Disease—MDM2—sarcoma	5e-05	0.000191	CbGpPWpGaD
Icosapent—Pruritus—Doxorubicin—sarcoma	4.92e-05	0.00512	CcSEcCtD
Icosapent—Vomiting—Epirubicin—sarcoma	4.78e-05	0.00497	CcSEcCtD
Icosapent—Rash—Epirubicin—sarcoma	4.74e-05	0.00493	CcSEcCtD
Icosapent—Dermatitis—Epirubicin—sarcoma	4.74e-05	0.00493	CcSEcCtD
Icosapent—Vomiting—Doxorubicin—sarcoma	4.42e-05	0.0046	CcSEcCtD
Icosapent—Rash—Doxorubicin—sarcoma	4.39e-05	0.00456	CcSEcCtD
Icosapent—Dermatitis—Doxorubicin—sarcoma	4.38e-05	0.00456	CcSEcCtD
Icosapent—PTGS2—Disease—CTNNB1—sarcoma	4.31e-05	0.000165	CbGpPWpGaD
Icosapent—PTGS2—Disease—SRC—sarcoma	3.9e-05	0.000149	CbGpPWpGaD
Icosapent—PTGS2—Disease—NRAS—sarcoma	3.75e-05	0.000144	CbGpPWpGaD
Icosapent—PTGS2—Disease—MYC—sarcoma	3.49e-05	0.000134	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—sarcoma	3.42e-05	0.000131	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—sarcoma	3.23e-05	0.000124	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—sarcoma	2.74e-05	0.000105	CbGpPWpGaD
